INTRODUCTION
============

The prevalence of food allergy has been increasing over the last decades. Many reports indicate that new eating habits associated with epigenetic factors may be responsible for this change worldwide ([@b1-cln_68p1004],[@b2-cln_68p1004]).

Sensitization, the first step in food allergy, is characterized by allergen-specific IgE production along with a Th2 immune response, inflammatory cytokine release and the onset of signs and symptoms ([@b3-cln_68p1004]). Despite the daily ingestion of many proteins in the diet, only a few are associated with clinical manifestations of allergy: cow\'s milk (CM), soy, eggs, peanuts, wheat, nuts, fish and crustaceans ([@b4-cln_68p1004],[@b5-cln_68p1004]). CM allergy (CMA) is one of the leading causes of food allergy in childhood, affecting 2.5% of children under the age of 3 and 6% of children under the age of 4 ([@b4-cln_68p1004]). CM proteins, such as casein, beta-lactoglobulin and alpha-lactalbumin, may be involved in long-term immunological learning ([@b6-cln_68p1004]). Although most patients overcome the allergy, the persistence of CMA has been reported ([@b7-cln_68p1004]). CMA prognosis is usually good in patients developing tolerance up to 3 years of age, although recent studies have shown more severe outcomes in patients with IgE-mediated CMA ([@b5-cln_68p1004]). The persistence of CMA has also been associated with sensitization to casein and the occurrence of anaphylaxis ([@b6-cln_68p1004]).

Predictive markers of persistent CMA have been extensively studied to identify groups eligible for new treatments targeted to induce tolerance, such as immunotherapy with food allergens associated with bacterial products or the use of genetically modified allergens. A number of regulatory cells play a key role in the immune response to food, including (CD4^+^CD25^+^) lymphocytes (Treg), Th3 cells and T regulatory type 1 cells (Tr1), which produce immunoregulatory cytokines, such as transforming growth factor β1 (TGFβ1) and interleukin 10 (IL10). A reduction in TGFβ1 production due to the inadequate stimulation of innate immunity by intestinal microflora may contribute to the failure of oral tolerance ([@b8-cln_68p1004]). Several studies have associated low TGFβ1 levels with sensitization to food ([@b8-cln_68p1004],[@b9-cln_68p1004]). The deletion/anergy of reactive T cells against specific antigens associated with the expanding population of regulatory T cells and the production of IL10 are mechanisms involved in oral tolerance ([@b3-cln_68p1004]).

The present study aimed to investigate whether the presence of single nucleotide polymorphisms (SNPs) in such immunoregulatory genes as IL10 and TGFβ1 are associated with demographic and clinical data in order to better characterize the group of children at a high risk of evolving persistent CMA.

MATERIALS AND METHODS
=====================

Ethics statement
----------------

Written informed consent was obtained from all participants, and the study was approved by the Internal Review Board of the University of São Paulo (CAPpesq n°1107/07, 03/17/2008). Permission to use DNA samples from HCs was also granted strictly according to the Brazilian Ethical Committee guidelines (CAPpesq n°560/00, 08/09/2002).

Study population
----------------

This study enrolled 50 children older than 5 years of age with IgE-mediated CMA who were followed up at the Child Institute, General Hospital, Faculdade de Medicina da Universidade de São Paulo, Brazil. The children were diagnosed according to the following criteria: anaphylaxis triggered by CM or immediate clinical reactivity induced by CM during a double-blind, placebo-controlled food challenge (DBPCFC). The patient group was compared with 224 HCs recruited from bone marrow donors at the same hospital. These individuals were clinically evaluated to exclude any type of allergy.

DNA preparation
---------------

Blood samples were obtained from the CMA patients. Genomic DNA was extracted according to the DTAB/CTAB method ([@b10-cln_68p1004]).

SNP selection and genotyping
----------------------------

The choice of SNPs was made on the basis of the SNPs\' role in cytokine production ([@b11-cln_68p1004]-[@b13-cln_68p1004]).

SNPs located at the promoter region of the IL10 gene or at the -3575 (rs1800890), -2849 (rs6703630), -2763 (rs6693899) or -592 (rs1800872) position were tested by polymerase chain reaction (PCR)-RFLP according to previously described protocols ([@b14-cln_68p1004],[@b15-cln_68p1004]).

Briefly, PCR was performed in a final volume of 25 μL containing 100 ng of genomic DNA, 40 μM dNTP, 0.2 U of Taq polymerase, 1.5 mM MgCl~2~ and 0.25 pM of each primer. In the case of the -592 SNP, 2.0 mM MgCl~2~ and 0.5 pM of each primer was used. The PCR conditions were an initial denaturation step at 95°C for 5 min, followed by 35 cycles at 95°C for 20 s; annealing temperatures of 62°C (-3575), 60°C (-2849 and -2763) or 56°C (-592) for 30 s; and an extension step at 72°C for 20 s, ending with 7 min at 72°C. An aliquot of 10 μL of the PCR product was digested for 3 h at 37°C with 2.5 U of Apo I (-3575), 2.5 U of Alw I (-2849), 5 U of Dde I (-2763) or 3.0 U of Rsa I (all enzymes from New England Biolabs, Ipswich, MA) in a total volume of 20 μL. Digestion products were separated by electrophoresis in 4% agarose gels, stained with ethidium bromide and visualized under UV light.

The IL10 -1082 polymorphism (rs1800896) was genotyped using an allele-specific PCR (ASPCR). The specific primer S1 or S2 paired with the common primer C were used to amplify a 258 bp fragment ([@b16-cln_68p1004]). The housekeeping hGH gene was used as an internal control, yielding a 480 bp amplification product. PCR was performed using the same conditions as for the IL10 -592 polymorphism.

The TGFβ1 -509 polymorphism (rs1800469) was typed by PCR-RFLP with primers described elsewhere ([@b17-cln_68p1004]). Briefly, PCR-RFLP was performed in a final volume of 25 μL containing 100 ng of genomic DNA, 40 μM dNTP, 0.2 U of Taq polymerase, 1.5 mM MgCl~2~ and 0.25 pM of each primer, using the same protocol as for IL10 -592. An aliquot of 20 μL of the PCR product was digested for 3 h at 37°C with 3 U of Dde I (New England Biolabs) in a total volume of 40 μL. Digestion products were separated by electrophoresis in a 4% agarose gel, stained with ethidium bromide and visualized under UV light.

Statistics
----------

Considering a type I error to be 0.05 and a relative risk of 2.5, defined according to our significant results, the power was estimated to detect statistically significant differences for the SNP frequencies in the two studied groups (CMA and HC) EPI Center version 4.1 (Extreme Networks, Inc., Santa Clara, California, USA). The values obtained were 76% and 67% for IL10 -1082 G/A and TGFβ1 -509C/T, respectively, and 66% for IL10 -1082 G/A considering the CMA group (persistent, n = 36), indicating that our sample size was adequate to avoid false-negative association.

Genotype and allele frequencies were calculated by direct gene counting. Comparisons between the CMA and HC groups were performed by the *x*^2^ test along with calculation of the odds ratio (OR) and 95% confidence interval (CI). Statistical comparisons were performed using Fisher\'s exact test whenever a value in the contingency table was below five and to perform genotype analysis using GraphPad Prism version 5.0 software. The p values were corrected for the number of different alleles tested (pc). Statistical significance was defined as a p value less than 0.05. Haplotype frequency, Hardy-Weinberg expectation (HWE) and linkage disequilibrium (LD) analyses were performed using Arlequin 3.1 software ([@b18-cln_68p1004]).

A logistic regression model was applied, considering the development of tolerance as a dichotomous variable, and continuous and qualitative parameters in univariate analysis were considered to be independent variables. Parameters with *p*\<0.2 (sex, anaphylaxis, the presence of other allergic diseases, IgE serum levels and specific IgE) were initially included in the multivariable analysis, and only those parameters with *p*\<0.05 were considered to be significant. These analyses were performed considering genotypes and allele carriage (the number of individuals having the allele on either one or both chromosomes). IgE levels (BN100; Siemens Healthcare Diagnostics, Marburg, Germany) were categorized into two groups: normal and elevated, according to the reference interval defined for each age by the manufacturer.

RESULTS
=======

Clinical features of and laboratory findings for the children with CMA
----------------------------------------------------------------------

The 50 studied patients were divided into two groups according to their clinical evolution: 36 patients were classified with persistent CMA (group P) and 14 were classified with tolerant CMA (group T). The onset of disease occurred very early in both groups, with no difference in the median age, although signs and symptoms appeared later in the persistent CMA group (15 *vs* 2 days). Familial atopy was slightly more frequent in the persistent CMA group compared with the tolerant CMA group (72% *vs* 57%). Anaphylaxis was associated with the persistent CMA group (*p* = 0.004). Similar trends were observed regarding the presence of wheezing (*p* = 0.018) and other allergies, such as asthma, rhinitis or dermatitis (*p* = 0.031) ([Table 1](#t1-cln_68p1004){ref-type="table"}).

Association of TGFβ1 and IL10 gene polymorphisms with CMA
---------------------------------------------------------

All six genotyped SNPs are in HWE. The five IL10 polymorphisms were in strong LD (data not shown). We observed a statistically significant difference in both the allele and the genotype distributions of the IL10 -1082 G/A polymorphism when CMA patients were compared with HCs. Homozygosis for the G allele was higher in the CMA group compared with the HC group (19 *vs* 12%; *p* = 0.027), but this difference was not maintained after Bonferroni correction (pc = 0.054) or in patients with persistent CMA compared with HCs (24 *vs* 12%; *p* = 0.001; pc = 0.002). The genotype containing the G allele (AG plus GG *vs* AA) was significantly more frequent in the persistent CMA group compared with the tolerant CMA group (OR = 6.77, 95% CI 1.59-28.73, *p* = 0.006). The presence of the G allele conferred a twofold risk of developing persistent CMA (OR = 2.43, 95% CI 1.45-4.08, *p*\<0.001), and the risk was even higher in the persistent CMA group compared with the tolerant CMA group (OR = 3.24, 95% CI 1.20-8.76, *p* = 0.017) ([Table 2](#t2-cln_68p1004){ref-type="table"}).

The presence of the CC genotype in the TGFβ1 -509C/T promoter region showed an initial association with persistent allergy compared with the genotype in tolerant patients (14% *vs* 42%; *p* = 0.048) that was not maintained after correction (pc = 0.096).

The remaining studied polymorphisms (IL10 -3575, IL10 -2849, IL10 -2763 and IL10 -592) showed no association with CMA ([Supplementary Table 1](#t4-cln_68p1004){ref-type="table"}).

Due the LD observed at the studied IL10 polymorphisms ([Figure 1](#f1-cln_68p1004){ref-type="fig"}), we analyzed the haplotypes containing these SNPs, except for -892, which was excluded from this study due to a strong association with -592 (r^2^ = 0.99). Three different SNP combinations showed an association with CMA. Curiously, the IL10 -3575A, IL10 -2849A, IL10 -2763C, IL10 -1082G and IL10 -592C haplotypes, strongly associated with CMA compared with HCs (*p*\<0.001; OR = 4.71, 95% CI, 1.86-11.9 ([Table 3](#t3-cln_68p1004){ref-type="table"}), were completely absent in the tolerant CMA group (data not shown).

Association of polymorphisms with clinical features
---------------------------------------------------

Several demographic and clinical variables, such as sex, anaphylaxis, the presence of other allergic diseases and total and specific IgE serum levels were analyzed together with the six SNPs studied, comparing tolerant with persistent CMA patients by means of a logistic regression model. The results confirmed that the G allele carriage (AG plus GG) at the IL10 -1082A/G polymorphism and homozygosis for the C allele at the TGFβ1 -509 T/C polymorphism were associated with persistent CMA (*p* = 0.019 and *p* = 0.047, respectively).

DISCUSSION
==========

In this study, we analyzed the main clinical characteristics of 50 children with CMA and investigated whether the IgE-mediated persistent form could be at least partially related to the presence of SNPs in the promoter region of the IL10 and TGFβ1 genes, leading to the altered expression of these inflammation markers, which are involved in the gastrointestinal immune response and the development of food tolerance.

To our knowledge, this is the first Brazilian study of children with CMA that has attempted to associate genetic aspects with IgE-mediated persistent disease. TGFβ1 has a fundamental role in intestinal homeostasis and oral tolerance to low antigen doses. In the gastrointestinal tract, this protein is secreted by lymphocytes, contributing to IgA secretion. Yamagiwa et al. (2001) showed that TGFβ1 may also contribute to the expansion of Treg ([@b8-cln_68p1004]). Moreover, a reduction in TGFβ1 production by the intestinal mucosal cells of children with food allergy has been described ([@b9-cln_68p1004]). A TGFβ1 gene polymorphism at the -509 position is associated with low cytokine levels caused by the modification of the Yin Yang 1 transcription factor consensus binding site when the allele C is present. Our findings are consistent with homozygosis of the C allele (low producer) being associated with the persistent form of CMA, but this result must be confirmed by further studies. Several studies have associated reduced levels of TGFβ1 sensitization with foods ([@b8-cln_68p1004],[@b9-cln_68p1004]). The mechanism of oral tolerance involves the deletion or anergy of T cells reactive with specific antigens associated with the expanding population of regulatory T cells following the production of TGFβ1 and IL10 ([@b3-cln_68p1004]).

One of IL10\'s main roles is the induction of oral tolerance, which has been evidenced by the association of IL10 levels with oral tolerance ([@b19-cln_68p1004]). Children with CMA who develop tolerance have a high regulatory T cell (CD4^+^ CD25^+^) count and a reduced proliferative response to beta-lactoglobulin in vitro compared with children with clinically active disease ([@b20-cln_68p1004]). Negoro et al. found an association of the A allele at the IL10 -627 position with the low expression of this cytokine, IgE levels and the severity of food allergy ([@b20-cln_68p1004]). Different studies have associated IL10 polymorphisms with asthma phenotypes in children, atopic dermatitis, the number of circulating eosinophils and IgE levels ([@b21-cln_68p1004],[@b22-cln_68p1004]). Our data showed the association of the G allele at the IL10 -1082A/G position with CMA. The reactivity of T cells in children with CMA is associated with IL10 production ([@b23-cln_68p1004]). Previous data showed an association of the GG genotype with an exacerbation of asthma in Costa Rican children exposed to dust mite allergens ([@b24-cln_68p1004]). A recent study showed a functional role for this polymorphism, as the presence of the A allele is associated with susceptibility to and the outcome of sepsis ([@b13-cln_68p1004]). George et al. demonstrated that the A allele at the IL10-1082A/G position is associated with lower IL10 expression ([@b25-cln_68p1004]). Conversely, Giordani et al. observed increased IL10 expression in the presence of the allele G at -1082 position ([@b26-cln_68p1004]). A recent study shows that polymorphisms in the IL10 gene may modify its effect in asthmatics\' airways ([@b27-cln_68p1004]). Corroborating findings were observed in an Egyptian study ([@b28-cln_68p1004]), demonstrating the important role of IL10 in allergic processes.

Different SNP combinations in the IL10 gene may impact cytokine production ([@b29-cln_68p1004]) and thus the outcome of immunological diseases. In the present study, we observed an association of IL10 haplotypes with CMA and with the persistent form of the disease. However, the ethnic heterogeneity of our population might be a bias due to the observed difference in IL10 polymorphism between Brazilian and African-derived populations ([@b30-cln_68p1004]). Increased expression levels of IL10 imply the greater control of inflammatory diseases but can also lead to more severe infectious conditions in which the effector response, rich in IFN and TNFα, is important. Haplotypes of polymorphisms in the promoter region of IL10 have been associated with increased levels of IgE in atopic dermatitis ([@b31-cln_68p1004]) and celiac disease ([@b32-cln_68p1004]). The interpretation of our haplotype analysis of polymorphisms in the IL10 gene is difficult due the number of analyzed individuals. Nevertheless, the power results showed that our sample size was adequate to analyze the IL10 -1092 A/G results individually. Of note, greater knowledge of the production of IL10 was linked to different haplotypes as biological relevant changes in the promoter region that usually alter the anchoring of different transcription factors, leading to differences in gene transcription.

In summary, our data have shown that the *IL10* gene is associated with the persistent form of CMA in this population of Brazilian children. Further studies, including a study of blood cytokine levels, must be performed to confirm the functional role of these cytokines in CMA.
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###### 

Clinical and laboratory characteristics of patients with persistent or tolerant, IgE-mediated cow\'s milk allergy.

                                Tolerant     Persistent   *p*-value
  ----------------------------- ------------ ------------ -----------
  Sex F/M                       8/6          13/23        ns
  Age of onset (days)                                     
      Median                    135          120          ns
      Range                     2-330        15-600       
  Diagnosis (days)                                        
      Median                    195          180          ns
      Range                     20-900       15-690       
  Follow-up (months)                                      
      Median                    48           46           ns
      Range                     11-124       5-164        
  Family atopy                  8            26           ns
  Anaphylaxis                   3            24           0.004
  Manifestation                                           
      Cutaneous                 13           34           ns
      Gastrointestinal          8            24           ns
      Respiratory               7            26           0.018
      Wheezing                  1            27           
  Other food allergies          3            12           ns
  Other allergies^a^            6            27           0.031
  IgE (IU/mL)                                             
      Median                    186.5        473          ns
      Range                     9.3-10,180   43-6,740     
  Specific IgE (\>0.35/total)                             ns
  CM                            14/14        33/35        ns
  Alpha                         8/10         20/23        ns
  Beta                          9/11         21/23        ns
  Casein                        10/11        21/24        ns

ns = not significant; ^a^asthma, rhinitis or dermatitis.

###### 

Genotype and allele frequency of IL10 -1082 A/G polymorphism in children with cow\'s milk allergy and in healthy controls (HCs).

  lL10 -1082A/G                    T (n = 13)   *p*-value (n = 34)   Total (n = 47)   HC (n = 217)   *p*-value   pc        *x*^2^   OR     95% CI
  -------------------------------- ------------ -------------------- ---------------- -------------- ----------- --------- -------- ------ ------------
  **Genotype**                                                                                                                             
  AA                               7 (54)       5 (14)               12 (26)          100 (46)                                             
  AG                               5 (38)       21 (62)              26 (55)          91 (42)        0.032       ns        6.90            
  GG                               1 (8)        8 (24)               9 (19)           26 (12)                                              
  **Genotype comparisons**                                                                                                                 
  AA *vs* GG                                                                                                                               
  CMA *vs* HC                                                                                        0.027       ns        4.90     2.89   1.10-7.58
  T *vs* HC                                                                                          ns                                    
  P *vs* HC                                                                                          0.001       0.002     10.67    6.15   1.86-20.39
  P *vs* T                                                                                           ns                                    
  AG and GG *vs* AA                                                                                                                        
  CMA *vs* HC                                                                                        0.001       0.002     6.68     2.49   1.23-5.06
  T *vs* HC                                                                                          ns                                    
  P *vs* HC                                                                                          \<0.001     \<0.001   11.89    4.96   1.85-13.29
  P *vs* T                                                                                           0.006       0.016     7.58     6.77   1.59-28.73
  **Allele**                                                                                                                               
  A                                19 (73)      31 (46)              50 (53)          291 (67)                                             
  G                                7(27)        37 (54)              44 (47)          143 (33)                                             
  **Allele comparison A *vs* G**                                                                                                           
  CMA *vs* HC                                                                                        0.011       0.022     6.49     1.74   1.14-2.81
  T *vs* HC                                                                                          ns                                    
  P *vs* HC                                                                                          \<0.001     \<0.001   11.77    2.43   1.45-4.08
  P *vs* T                                                                                           0.017       0.034     5.71     3.24   1.20-8.76

HC = healthy control; n = number of individuals; *x*^2^\$ = Chi-square; OR = odds ratio; ns = not significant.

###### 

IL10 (-3575A/T, -2849A/G, -2763A/C, -1082A/G, -592A/C) haplotype frequency in children with cow's milk allergy (CMA) and in healthy controls (HCs).

  IL10 -3575   IL10 -2849   IL10 -2763   IL10 -1082   IL10 -592   HC            CMA          *x*^2^   *p*-value                                           OR     95% CI
  ------------ ------------ ------------ ------------ ----------- ------------- ------------ -------- --------------------------------------------------- ------ ------------
                                                                  n = 434 (%)   n = 90 (%)                                                                       
  A            A            A            G            C           37 (8)        2 (3)                 ns                                                         
  A            A            C            G            C           10 (2)        9 (10)       12.63    \<0.001                                             4.71   1.86-11.9
  A            G            A            A            C           8 (2)         4 (5)                 ns                                                         
  A            G            A            G            C           29 (7)        1 (1)                 ns                                                         
  T            G            A            A            C           4 (1)         6 (7)                 0.027[\*](#tfn4-cln_68p1004){ref-type="table-fn"}   7.67   2.12-27.81
  T            G            C            A            A           136 (31)      25 (27)               ns                                                         
  T            G            C            A            C           116 (27)      9 (10)       11.48    \<0.001                                             0.31   0.16-0.63
  T            G            C            G            A           13 (3)        5 (5)                 ns                                                         
  T            G            C            T            G           39 (9)        10 (12)               ns                                                         
  Other\*\*    43 (10)      18 (20)                                                                                                                              

HC = healthy control; *x*^2^ = Chi-square; OR = odds ratio;

\*Fisher\'s exact test;

\*\*frequencies less than 5%. ns = not significant; n = sample size, referring to the number of chromosomes.

###### 

Genotype frequency of TGFb1 -509T/C, IL10 -3575A/T, IL10 -2849 A/G, IL10 -2763 C/A and IL10 - 592A/C, comparing children with cow\'s milk allergy with healthy individuals and comparing the tolerant form with the persistent form in CMA patients.

                                                                CMA                            
  -------------------- ------------ ----------- ------ -------- ----------- ----------- ------ ------------
  **TFGB1-509**                                                                                
      CC               36 (0.38)    17(0.34)                    2 (0.14)    15 (0.42)   6.06   **0.0484**
      CT               39 (0.41)    19 (030)    0.89   0.6419   9 (0.64)    10 (0.27)          
      TT               20 (0.21)    14 (0.38)                   3 (0.33)    11 (0.31)          
  ** TOTAL**           95           50                          14          36                 
  **IL10** **-3575**                                                                           
      AA               13 (0.06)    5 (0.22)                    2 (0.14)    3 (0.09)    0.47   0.7906
      AT               77 (0.35)    20 (0.28)   2.83   0.2428   5 (0.36)    15 (0.44)          
      TT               134 (0.60)   23 (0.50)                   7 (0.50)    16 (0.47)          
  ** TOTAL**           224          49                          14          34                 
  **IL10-2849**                                                                                
      AA               12 (0.05)    1 (0.02)                    1 (0.07)    0 (0.00)    4.52   0.1045
      AG               52 (0.23)    19 (0.39)   5.54   0.0626   3 (0.21)    16 (0.46)          
      GG               160 (0.71)   29 (0.59)                   10 (0.71)   19 (0.54)          
  ** TOTAL**           224          49                          14          35                 
  IL10**-2763**                                                                                
      AA               21 (0.09)    3 (0.06)                    1 (0.07)    2 (0.06)    0.40   0.8188
      AC               66 (0.29)    22 (0.44)   4.16   0.1251   7 (0.50)    15 (0.42)          
      CC               138 (0.62)   25 (0.50)                   6 (0.43)    19 (0.52)          
  ** TOTAL**           224          50                          14          36                 
  **IL10-592**                                                                                 
      AA               32 (0.14)    7 (0.15)                    2 (0.18)    5 (0.14)    1.02   0.5944
      AC               95 (0.42)    24 (0.51)   1.33   0.5154   8 (0.62)    16 (0.44)          
      CC               97 (0.43)    16 (0.34)                   3 (0.23)    13 (0.36)          
  ** TOTAL**           224          47                          13          36                 

HC = healthy control; CMA = cow\'s milk allergy; *x*^2^ = Chi-square.
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